Skip to main content
Clinical Trials

LS0386, Clinical and Epidemiological Studies in Lymphoma (CTMS#18-0162)

Cancer Type

Other Hematopoietic Identifier


Principal Investigator

Adolfo "Enrique" Diaz Duque, MD, MS

For more information about this study
View Details

About This Study

The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term outcomes. These efforts will identify new approaches to improve the survival and well-being of NHL patients.

What is the criteria to participate?

Note: This is only a partial list of eligibility criteria.

Inclusion Criteria:
Inclusion criteria
  • Newly diagnosed non-Hodgkin Lymphoma (NHL), within 183 days of enrollment
  • Patients may have been treated as long as initial NHL diagnosis is within 6 months of enrollment
  • 18 years of age or older
Exclusion Criteria:
Exclusion Criteria
  • Lymphoma diagnosis greater than 184 days from date of consent